According to ChromaDex's latest financial reports the company's total debt is $3.27 M. A companyโs total debt is the sum of all current and non-current debts.
Year | Total debt | Change |
---|---|---|
2023-12-31 | $3.27 M | -23.02% |
2022-12-31 | $4.25 M | -9.46% |
2021-12-31 | $4.7 M | 187.23% |
2020-12-31 | $1.63 M | -4.77% |
2019-12-31 | $1.71 M | 454.52% |
2018-12-31 | $0.31 M | -38.74% |
2017-12-31 | $0.5 M | -15.53% |
2016-12-31 | $0.59 M | -89.18% |
2015-12-31 | $5.53 M | 99.81% |
2014-12-31 | $2.77 M | 561.16% |
2013-12-31 | $0.41 M | 85.8% |
2012-12-31 | $0.22 M | -6.8% |
2011-12-31 | $0.24 M | -12.49% |
2010-12-31 | $0.27 M | 272.35% |
2009-12-31 | $0.07 M | -51.36% |
2008-12-31 | $0.15 M |
Company | Total debt | differencediff. | Country |
---|---|---|---|
Sangamo Therapeutics
SGMO | $38.1 M | 1,062.77% | ๐บ๐ธ USA |
Exelixis EXEL | $0.20 B | 6,047.88% | ๐บ๐ธ USA |